Get Published | Subscribe | About | Write for Our Blog    

Author Archive: Jennifer Miller, PhD

About Jennifer Miller, PhD

[WSJ/MSN] —While waiting for an infusion of a drug that might save his life, 15-year-old Andrew Marella gripped the controls of an NFL videogame, the hand-held version of a sport he played when he could still run without fear. Andrew is in a clinical drug trial of cyclodextrin, a sugar-based substance that scientists hope will […]

Full Article

[Gizmodo] Today, 23andMe announced what Forbes reports is only the first of ten deals with big biotech companies: Genentech will pay up to $60 million for access to 23andMe’s data to study Parki nson’s. You think 23andMe was about selling fun DNA spit tests for $99 a pop? Nope, it’s been about selling your data all along. Since 23andMe started in […]

Full Article

[NYTimes] A federal judge in New York has agreed to hear oral arguments in a lawsuit filed against the United Nations by advocates for Haitian victims of the deadly cholera epidemic that first appeared on the island four years ago. The lawsuit, filed last year, argues that United Nations peacekeepers in Haiti were responsible for […]

Full Article

Jennifer E. Miller on NPR’s Tech Nation discussing the ethics and trustworthiness of the pharmaceutical industry and whether a rating system could help improve both, where needed.  Moira Gunn interviews Dr. Miller at minute 35 to the end. http://technation.podomatic.com/entry/2014-08-25T13_49_01-07_00

Full Article

[NPR] No one likes it when a new drug in people’s medicine cabinets turns out to have problems — just remember the Vioxx debacle a decade ago, when the painkiller was removed from the market over concerns that it increased the risk of heart attack and stroke. To do a better job of spotting unforeseen risks […]

Full Article

[CNBC] wo years ago, Nathalie Traller spent her days like any seventh-grader might. She played soccer and swam and studied for classes. Then Nathalie started getting bad headaches, the kind that made it hard for her to concentrate. A trip to the doctor revealed the unthinkable: a mass the size of a baseball in her […]

Full Article

The latest revisions to the Declaration of Helsinki may weaken human research subject protections, particularly for participants in low and middle income countries, according to a recent analysis in BMJ.  See the article here:  http://www.bmj.com/content/349/bmj.g4254

Full Article

[Forbes] Merck says that it “regrets” using legal threats to push a leading Italian researcher to muffle his public critiques of one of the company’s cholesterol drugs. Merck spokesman Steve Cragle writes: Merck is committed to the open and transparent exchange of scientific information. We believe this exchange should take place in medical meetings and […]

Full Article

[TheEconomicTimes] Pharmaceutical companies having more than a 1% market share for any essential drugs may find it difficult to stop manufacturing those products. Since May, when the government brought into force a new drug-pricing system after a gap of 18 years, the National Pharmaceutical Pricing Authority has denied such requests whenever the market share of […]

Full Article

[Bloomberg] A widely publicized warning by U.S. regulators a decade ago about risks for teenagers taking antidepressants led to plummeting prescriptions and increased suicide attempts, Harvard University researchers said. As the public took the Food and Drug Administration’s 2004 warning to heart, adolescent attempted suicides increased 21.7 percent and a 31 percent decline in antidepressant […]

Full Article